Study dispels myth that cancer biopsies cause cancer spread
the ONA take:
According to a new study published in the journal Gut, researchers at the Mayo Clinic in Jacksonville, Florida, have found that cancer biopsies do not cause cancer to spread and that patients who underwent a biopsy had better outcomes than those who did not receive one.
For the study, researchers analyzed the Medicare data of over 2,000 patients with non-metastatic pancreatic cancer who underwent surgery for their disease. Of those, about approximately 500 had an ultrasound-guided fine needle aspiration, while the other 1,500 did not.
Results showed that during a median follow-up time of 21 months, 57% of those who received a biopsy and 76% of those that did not died. Fifty percent of those in the biopsy group compared with 64% of the non-biopsy group were found to have died as a result of pancreatic cancer.
Furthermore, the median overall survival in the biopsy group was 22 months versus 15 months in the non-biopsy group. The findings suggest that the minimally invasive fine needle aspiration technique does not causes cancer to spread, and undergoing a biopsy even improves mortality and overall survival.
This study does not only apply to those with pancreatic cancer as the fine needle aspiration technique is used across various tumor types.
Cancer biopsies do not cause cancer to spread.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|